AM-630

CAS No. 164178-33-0

AM-630 ( AM 630;AM630;6-Iodopravodoline )

Catalog No. M12488 CAS No. 164178-33-0

A potent and selective inverse agonist for the cannabinoid receptor CB2 with Ki of 32.1 nM, 165-fold selectivity over CB1.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 41 Get Quote
5MG 60 Get Quote
10MG 87 Get Quote
25MG 199 Get Quote
50MG 327 Get Quote
100MG 520 Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    AM-630
  • Note
    Research use only, not for human use.
  • Brief Description
    A potent and selective inverse agonist for the cannabinoid receptor CB2 with Ki of 32.1 nM, 165-fold selectivity over CB1.
  • Description
    A potent and selective inverse agonist for the cannabinoid receptor CB2 with Ki of 32.1 nM, 165-fold selectivity over CB1; inhibits forskolin-stimulated cyclic AMP production in CB1-transfected cells (22.6% at 1 uM and 45.9% at 10 uM).
  • Synonyms
    AM 630;AM630;6-Iodopravodoline
  • Pathway
    GPCR/G Protein
  • Target
    Cannabinoid Receptor
  • Recptor
    Cannabinoid Receptor
  • Research Area
    Neurological Disease
  • Indication
    ——

Chemical Information

  • CAS Number
    164178-33-0
  • Formula Weight
    504.40
  • Molecular Formula
    C23H25IN2O3
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    O=C(C1=C(C)N(CCN2CCOCC2)C3=C1C=CC(I)=C3)C4=CC=C(OC)C=C4
  • Chemical Name
    [6-iodo-2-methyl-1-[2-(4-morpholinyl)ethyl]-1H-indol-3-yl](4-methoxyphenyl)-methanone

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Ross RA, et al. Br J Pharmacol. 1999 Feb;126(3):665-72.
2. Malan TP Jr, et al. Pain. 2001 Sep;93(3):239-45.
molnova catalog
related products
  • UR-144

    A potent, selective full agonist of the peripheral cannabinoid receptor CB2 with Ki of 1.8 nM.

  • A 834735

    A potent, nonselective, brain penetrant, full agonist at both the central CB1 and peripheral CB2 receptors with Ki of 4.6 and 0.31 nM, respectively.

  • Repertaxin

    Reparixin is a potent inhibitor of both CXCL8 receptorsCXCR1/2, it inhibits weaklyCXCR2-mediated cell migration (IC50=100 nM), whereas it strongly blocksCXCR1-mediated chemotaxis (IC50=1 nM).